Clinical Trial: Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial

Brief Summary:

OBJECTIVES:

I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.